Chimera Investment
CIM

Chimera Investment (CIM) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
Keefe, Bruyette & WoodsMaintainedMarket Perform$14.00 from $15.00Aug 6, 2026
RBC CapitalMaintainedSector Perform$14.00Jun 3, 2026
UBSMaintainedBuy$15.50 from $16.00Nov 18, 2025
Keefe, Bruyette & WoodsMaintainedMarket Perform$15.00 from $16.50Jul 10, 2025
UBSMaintainedBuy$16.00 from $15.00Jul 10, 2025
UBSUpgradedNeutral → Buy$15.00 from $11.50May 14, 2025
JMP SecuritiesMaintainedMarket PerformJan 23, 2025
Keefe, Bruyette & WoodsMaintainedMarket Perform$16.00 from $15.00Aug 8, 2024
Keefe, Bruyette & WoodsMaintainedMarket Perform$15.00Jul 10, 2024
UBSInitiated CoverageNeutral$5.50Dec 6, 2023
Credit SuisseMaintainedNeutral$5.50 from $6.50May 19, 2023
RBC CapitalMaintainedOutperform$6.00 from $7.00May 17, 2023
Keefe, Bruyette & WoodsMaintainedMarket Perform$5.50 from $6.25May 9, 2023
Keefe, Bruyette & WoodsMaintainedMarket Perform$6.25 from $7.00Apr 24, 2023
Credit SuisseMaintainedNeutral$6.50Mar 9, 2023
RBC CapitalMaintainedOutperform$7.00Mar 7, 2023

Frequently asked questions

  • What is the latest analyst rating on CIM?

    On Aug 6, 2026, Keefe, Bruyette & Woods maintained Chimera Investment at Market Perform with a price target of $14.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.